Do want to get some insights into the intricate working of your immune system? Navigating the Cancer Maze, Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.
Do want to get some insights into the intricate working of your immune system and cancer? On Navigating the Cancer Maze, internet radio Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.
PROF DR. JEROME GALON
Listen to the show by selecting the following link:
Professor Galon’s current interests & major contributions concern basic & translational research in cancer immunology, using systems biology.
His laboratory has made some ground-breaking findings demonstrating that the adaptive immune response within a tumor was a better predictor of survival than traditional staging based on the size and spread of a tumor.The new wave of immunotherapies reflects what has been known for some time; that the answer to cancer is in you! But it is not that simple. Our immune system is complex and intricate & as science unravels its mysteries, we are developing new understandings of how the immune system can be captured & recruited in the laboratory; retrained and returned to you the patient!
Awards: In 2008 Prof Dr Galon was awarded The Colon Cancer Research Schaeverbeke Award, Fondation de France,& the Clinical Research Award, Rose Lamarca, Fondation pour la Recherche Médicale.
INSERM Laboratory of Prof Jerome Galon Integrative Cancer Immunology (Team 15) Cordeliers Research Center
In 2010 he received the William B. Coley Award from the Cancer Research Institute, NY, USA, 2011: the French National Academy of Science & the French National Academy of Medicine (2011) awards.
He has published many scientific papers and book chapters.
It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM).
Free informational cancer seminars Brisbane June 15 – 21 2014 Brisbane.
Click the link below to see other events presented by QIMR – for immunology week June 15 – 21 2014 Brisbane.
Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna Joins Grace Gawler on Navigating The Cancer Maze To Talk about a Brain Cancer breakthrough.
Phoenix, AZ — 06/13/2014 — Voice America Talk Radio Network, Internet broadcasting pioneer, producing and syndicating online audio and video, today announced that Professor Rajiv Khanna QIMR Berghofer Medical Research Institute Australia will join Grace Gawler host of Navigating the Cancer Maze program on the VoiceAmerica Health and Wellness Channel (http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze) Friday, June 13, 2014 at 12 noon Pacific Time.
NOTE: show goes live to air 5 am Brisbane Australia time Saturday 14 June 2014. Available streaming audio any time after 9 am this Saturday and available to download on itunes indefinitely.
It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM). Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression. “It is early days, but this is exciting,” Professor Khanna said.
“Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”
Image of Brain GBM
GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year. Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years. This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms.
Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said.
The QIMR is celebrating their research findings by hosting a series of immunology and cancer presentations between June 15 and June 21 in Brisbane. For those people who cannot attend, watch out on the websites for more information. www.qimrberghofer.edu.au or www.gracegawlermedia.com
The Phase I trials were conducted at Brisbane’s Wesley Hospital, under the leadership of neurosurgeon Professor David Walker. “Working with patients with malignant brain tumors can be distressing, because we know so many will succumb,” Professor Walker said. “But this new branch of therapy lets us offer some hope that the future is going to be brighter, that new and innovative treatments mean things will hopefully improve in the future. “We have a long way to go, and there is hard work to be done, but we seem to be on the right track, and it is a pleasure to work with scientists at QIMR Berghofer to try to make a real difference.”
The research team is now keen to begin the next phase of trials, involving patients at an earlier stage of the cancer’s development. “These would be patients who have just been diagnosed and are about to start the standard treatments – surgery, then radiotherapy or chemotherapy. We would generate the T cell therapy before their standard treatment, and then administer T cells in conjunction with the standard therapy,” Professor Khanna said.
“We hope that the treatment can be even more effective if given at an earlier stage of the disease.”
This study is published online in the prestigious US journal Cancer Research and can be viewed at http://cancerres.aacrjournals.org/content/early/recent
The research was funded by Flagship Funding from the Rio Tinto Ride to Conquer Cancer, the NHMRC and private donors.
The QIMR Berghofer Medical Research Institute is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.
For more information about QIMR Berghofer Visit: www.qimrberghofer.edu.au
Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month. Where is the answer to cancer? According to Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer!
Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month
June 6, 2014
Did you know that June is Cancer Immunotherapy Month? Tune in to Navigating the Cancer Maze for inspiring listening and learn about the good news – the Answer to Cancer
Dr. Jill O’Donnell-Tormey PhD CEO Cancer Research Institute NY
Where is the answer to cancer? According to my guest Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer! Select link below to listen to audio
The CRI is a non-profit organization founded in 1953 & today’s global leader in supporting & coordinating research aimed at harnessing the immune system’s power to conquer all cancers. Jill will explain immunotherapy & its value to cancer patients as well as the different types of cancer immunotherapy available. There will be patient stories & an exploration of the very latest in immunotherapy. A New Cancer Immunotherapy Website for Patients and Caregivers was launched recently. Get on board with supporters like Olivia Newton John who recently lent public support to CRI. http://www.cancerresearch.orghttp://www.TheAnswerToCancer.org
Listen to Navigating the Cancer Maze 12 Noon Fridays – live from Arizona (PST) – Saturday Australia 5am free to air or download and listen later – available free download on itunes.
Bio-Strath AG uses the Saccharomyces cerevisiae Meyen yeast type in the production of its natural Strath products. This yeast already contains many essential vital substances in itself. Strath strengthens immune defences
All you need to keep your immune system functional.
About Strath Tonic: Part 3
Herbal yeast – Production
Bio-Strath AG uses the Saccharomyces cerevisiae Meyen yeast type in the production of its natural Strath products. This yeast already contains many essential vital substances in itself.
During the gentle, biological Strath process, yeast cells are combined with selected herbal extracts as they multiply. The uptake and integration of the herbal active substances into the yeast cells creates the unique Strath herbal yeast. In a subsequent processing step, the yeast cells are naturally opened up, in other words liquefied.
This process, known as plasmolysis, is required so that the human body can take up the valuable constituents of Strath herbal yeast (bioavailability). The production process takes about 2 months in total. Strath is suitable for yeast intolerant people (listen to interview Voice America). The liquid contains minimal sugars while the tablets contain no sugars. The liquid is well tolerated by people with cancer who want to improve their wellbeing while undergoing cancer treatments.
LATEST RESEARCH: Influence of Bio-Strath® on osteogensis Herbal yeast plasmolysate promotes the osteogenic differentiation of human mesenchymal stem cells. (Monici M., Marziliano N., Cialdai F., romano G., Cellai I., Benvenuti S. und Cogoli A.; L?Integratore Nutrizionale; 14(1), 2011:37-42)
Summary of the results of the in-vitro-Study at the University of Florence, Italy:
The addition of herbal yeast clearly promotes maturation of cells that build up bone mass (osteoblasts).
The formation of undesirable osteoclasts (bone breakdown) is decreased by adding herbal yeast.
A combination of drug therapy and herbal yeast plasmolysate could therefore be successful in osteoporosis patients.
Part one of Understanding Cancer:
A key function of the Grace Gawler Institute is education about cancer. Being a veteran – I have seen a lot during my 35 years of working with cancer patients. Most cancer patients I see in my practice have foregone conventional therapy for what appears to be the more logical solution of natural remedies. Some choose not to have surgery and go totally natural while others have their initial surgery and refuse further treatments or future diagnostic monitoring. Surely our bodies know what to do – the theory being that if we can just get our bodies nourished by a flood of good food, juices and doses of mega supplements – that it will fix the multitude of dietary and lifestyle sins we have committed in the immediate past and the damage passed on to us via genes and damaged DNA – add to that mix the environmental pollutants of the present. Believe me – it is not that simple!
I was raised believing that good food and a healthy lifestyle can prevent certain illnesses and I believe that is a possibility; however times have changed and so has the environment we live in. We are often exposed to hundreds – maybe even thousands of cancer causing substances as we innocently go about our daily lives – it is a cost of the conveniences that we love, the products we use and the 20th and 21st century lifestyles we’ve lived.
Unlike 35 years ago when I began working with cancer patients, many patients who contact me now seem to have had quite reasonable diets; they are disappointed because they had tried in earnest to cancer-proof their lives by becoming vegetarian, vegan, juicing daily, exercising at the gym going to yoga and practising meditation daily and positive thinking etc. They are surprised to learn that yogis, naturopaths, meditators & natural lifestyle folk can all succumb to cancer. There must be more to this cancer riddle than seems obvious. Continue reading “Grace Gawler Grace Gawler Institute – why alternative medicine is often not enough in cancer treatment.”
